ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

MTFB Motif Bio Plc

0.50
0.00 (0.00%)
28 Mar 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Motif Bio Plc LSE:MTFB London Ordinary Share GB00BVVT4H71 ORD 0.01P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0.50 0.40 0.55 - 0.00 00:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Motif Bio Share Discussion Threads

Showing 2526 to 2549 of 9925 messages
Chat Pages: Latest  109  108  107  106  105  104  103  102  101  100  99  98  Older
DateSubjectAuthorDiscuss
30/10/2018
09:11
Very nervously now !!!!
philoosh
24/10/2018
12:04
Safe to say this is the most frustrating share i've ever owned. Fingers crossed we see some movement DEC or early JAN.
t-trader
17/10/2018
11:09
I'm holding, nervously.....
philoosh
16/10/2018
14:20
philoosh,

No significant news expected until Jan/Feb
Cash burn may indicate a placing may be needed before then
Broken down through previous support

On the plus side only 10 weeks now til the new year when this should start rising on anticipation imo - just have to hold and see

return_of_the_apeman
16/10/2018
10:47
Why is this tanking?
philoosh
11/10/2018
22:13
I’ve seen triple bottoms in porn vids. Very nice
volsung
11/10/2018
22:02
Needs to hold the triple bottom :-《
return_of_the_apeman
09/10/2018
16:45
3 weeks after the half year report and hitting 37p , it is back near it’s all time low.
And the same in the US!
Not promising!!!!

uncleoswald
09/10/2018
13:56
A lot of things have dropped over the last few days. Italy??
small crow
09/10/2018
13:30
what is the reason for the big drop off over the last few days?
philoosh
28/9/2018
14:57
Obiterdicta. I will align with you as I feel comfortable running with the herd (whatever bias that is called)
hashertu
28/9/2018
10:11
hashertu - good question. My reading of the implications are as follows:

1. The major shareholder won't need to sell to pay down the loan for at least a year - so no drip fed share sales.

2. The lender has done due diligence and sees that the shares are good security for the loan over a 12 month timeframe. The shares are good collateral and there is little risk of the shares not covering the loan principal if the shares need to be sold in a hurry.

It's a positive statement if you draw the above inferences from it. I might be subject to confirmation bias though. ;-)

OD

obiterdicta
28/9/2018
09:57
How might today's RNS about Amphion impact MTFB?
hashertu
28/9/2018
07:36
Motif Bio plc (AIM/NASDAQ: MTFB) is a clinical-stage biopharmaceutical company focused on developing novel antibiotics designed to be effective against serious and life-threatening infections caused by multi-drug resistant Gram-positive bacteria, including MRSA. The Company's lead product candidate is iclaprim. Following positive results from two Phase 3 trials (REVIVE-1 and REVIVE-2), a New Drug Application (NDA) was submitted to the U.S. Food & Drug Administration (FDA) for the treatment of acute bacterial skin and skin structure infections (ABSSSI) and is now under review, with a PDUFA date of February 13, 2019. More than 3.6 million patients with ABSSSI are hospitalised annually in the U.S. It is estimated that up to 26% of hospitalized ABSSSI patients have renal impairment

Not worried about fundraising after approval. With a course of iclaprim to be a minimum of $1,200, that's a potential $1billion of revenues from the US alone per annum

I have never been so confident about FDA approval for a new drug as with this submission so it's a binary play for me with exceptional probability of success.

Plan to aďd before the new year

We shall see.

dyor

return_of_the_apeman
25/9/2018
14:44
Its a hold rather than a buy until we have news on the FDA outcome. There will always be a sense of nervousness as we await news I remain very hopeful of a positive outcome and encouraged at the diligence that went into the submission. They have enough cash to get us to February however if it gets the green light I can understand why further fund raising will be required to bring it to market. In addition of course the production of a phase 3 trial will also require substantial funding.
catch007
25/9/2018
11:03
COMPANY FOR SALE.

BUYERS REQUIRED,!

Go on have a tilt, you may be lucky.

escapetohome
25/9/2018
10:25
It is disappointing there is no update on the submission to the EMA.
jane deer
25/9/2018
10:07
Company for sale.

Thats enough raisings and dilution.

escapetohome
25/9/2018
10:01
From the half year report:

" We continue to believe that iclaprim could be a useful agent for HABP. A Phase 3 trial is being planned and commencement remains subject to funding."

and

"As we near our PDUFA date, we continue to evaluate additional capital raising opportunities to fund our growth and continuing operations...."

No matter how much money they raise it never seems to be enough.

bandflex
17/9/2018
11:44
When is this gonna take off? I'm antsy.....
philoosh
15/9/2018
07:26
At all-time low in US!!
uncleoswald
06/9/2018
20:51
Only 5 months and the news may come sooner - expect the circus will arrive on the first trading day of the new year

Meanwhile in charty tea leaf land an inverse h&s on the chart points to a retest of 36p, strengthened by the double bottom

Wake me up in Feb when this is through the pound barrier

return_of_the_apeman
03/9/2018
06:38
Sbtx RNS boom time.Big rerate to come
costax1654x
22/8/2018
08:28
Being played like a bloody fiddle. Still, only 6 months to go now
l4z4rus
Chat Pages: Latest  109  108  107  106  105  104  103  102  101  100  99  98  Older

Your Recent History

Delayed Upgrade Clock